EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Possible role of hyperimmunoglobulin in reducing the risk of maternal–fetal transmission of cytomegalovirus in the valacyclovir era: a case series

Anna Barbiero, Daniele Lilleri, Piera d'Angelo, Federica Zavaglio, Matilde Tavanti, Sara Biagioni, Alessandra Ipponi, Michele Cecchi, Beatrice Borchi, Michele Salvatore Trotta, Lucia Pasquini, Alessandro Bartoloni und 1 weitere

Archives of Gynecology and Obstetrics · 27.04.2026 · 313 (1)

DOI: 10.1007/s00404-026-08432-0 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 27.04.2026. Verfasst von Anna Barbiero und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Antiviral Agents, Pregnancy Complications, Infectious, Infectious Disease Transmission, Vertical. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Valacyclovir is the only treatment option during pregnancy which has been demonstrated to be effective within a randomized clinical trial for prevention of transplacental cytomegalovirus (CMV) transmission. However, the use of high dose intravenous hyperimmunoglobulin (HIG) could reduce the rate of vertical transmission according to some observational studies. Cases presentation We report three peculiar cases in which high dose HIG was administered in substitution to or in addition to valacyclovir to reduce the risk of transplacental transmission of CMV. Two were immunocompromised pregnant women—one with recurrent CMV reactivations due to solid organ transplant-related immunosuppression and one with primary CMV infection and lack of IgG production due to anti-CD20 treatment for multiple sclerosis—in which HIG was co-administered with valacyclovir. The third case involved an immunocompetent pregnant woman to whom HIG was administered in substitution to valacyclovir due to severe gastrointestinal side effects related to the latter medication. In all cases, the treatment was well tolerated and the newborns tested negative for CMV at birth.

Conclusion

Together, these cases give an interesting perspective on the possible role of HIG in selected immunocompromised pregnant women with primary and non-primary CMV infection in addition to valacyclovir, and in immunocompetent pregnant women unable to tolerate valacyclovir or in whom the drug is contraindicated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsAntiviral AgentsPregnancy Complications, InfectiousInfectious Disease Transmission, VerticalImmunoglobulins, IntravenousAcyclovirHumansFemalePregnancyValacyclovirAdultInfant, NewbornImmunocompromised HostValine

Stichwörter der Autor:innen

CMVCongenital CMVHyperimmunoglobulinImmunocompromisedPregnancyValacyclovir

Substanzen

ValacyclovirAntiviral AgentsImmunoglobulins, IntravenousAcyclovirValine

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Hospital Pharmacy and Pharmaceutical Policies, Careggi University Hospital, Florence, Italy.
  • Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
  • Fetal Medicine Unit, Careggi University Hospital, Florence, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. lorenzo.zammarchi@unifi.it.

Förderung

  • Università degli Studi di Firenze

Zitieren

APA

Barbiero, A., Lilleri, D., d'Angelo, P., Zavaglio, F., Tavanti, M., Biagioni, S., Ipponi, A., Cecchi, M., Borchi, B., Trotta, M. S., Pasquini, L., Bartoloni, A., & Zammarchi, L. (2026). Possible role of hyperimmunoglobulin in reducing the risk of maternal–fetal transmission of cytomegalovirus in the valacyclovir era: a case series. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-026-08432-0

Vancouver

Barbiero A, Lilleri D, d'Angelo P, Zavaglio F, Tavanti M, Biagioni S, et al. Possible role of hyperimmunoglobulin in reducing the risk of maternal–fetal transmission of cytomegalovirus in the valacyclovir era: a case series. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-026-08432-0

BibTeX
@article{Barbiero2026,
  author = {Barbiero, Anna and Lilleri, Daniele and d'Angelo, Piera and Zavaglio, Federica and Tavanti, Matilde and Biagioni, Sara and Ipponi, Alessandra and Cecchi, Michele and Borchi, Beatrice and Trotta, Michele Salvatore and Pasquini, Lucia and Bartoloni, Alessandro and Zammarchi, Lorenzo},
  title = {Possible role of hyperimmunoglobulin in reducing the risk of maternal–fetal transmission of cytomegalovirus in the valacyclovir era: a case series},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  volume = {313},
  number = {1},
  doi = {10.1007/s00404-026-08432-0}
}
Kostenlos starten →